Major COVID-19 vaccine trial resumes in UK after safety review

United States News News

Major COVID-19 vaccine trial resumes in UK after safety review
United States Latest News,United States Headlines
  • 📰 rapplerdotcom
  • ⏱ Reading Time:
  • 48 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 86%

'Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so.'

Pharma giant AstraZeneca and Oxford University on Saturday, September 12, said they had resumed a COVID-19 vaccine trial after getting the all-clear from British regulators, following a pause caused by a UK volunteer falling ill.

An independent committee was drafted in to review safety, in what the company and the World Health Organization described as a routine step. After the pause, AstraZeneca had said it remained hopeful that the vaccine could still be available"by the end of this year, early next year". Charlotte Summers, lecturer in intensive care medicine at Cambridge University, welcomed the resumption of the Oxford trial and said the researchers had shown their commitment"to putting safety at the heart of their development programme."

The AZD1222 vaccine uses a weakened version of a common cold-causing adenovirus engineered to code for the spike protein that the COVID-19 coronavirus uses to invade cells. "The company will continue to work with health authorities across the world and be guided as to when other clinical trials can resume to provide the vaccine broadly, equitably and at no profit during this pandemic."

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

rapplerdotcom /  🏆 4. in PH

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Korda posts 1-shot lead in LPGA major – The Manila TimesKorda posts 1-shot lead in LPGA major – The Manila TimesRANCHO MIRAGE, California: Nelly Korda has had Grand Slam events on her mind for the last two weeks, not just her own, and she made it through the first round Thursday (Friday in Manila) of the ANA Inspiration with just the start she wanted. With heat-baked greens so firm she couldn’t find pitch marks, Korda […]
Read more »

Serena Williams upset by Victoria Azarenka at US Open, temporarily ending bid for record 24th majorSerena Williams upset by Victoria Azarenka at US Open, temporarily ending bid for record 24th majorSerena Williams enjoyed her best start at this year's US Open on Thursday but it was a familiar foe, Victoria Azarenka, who finished the stronger to halt her friend and fellow mom's quest for a record 24th grand slam title.
Read more »

Britain clinches first major trade deal since leaving the EUBritain clinches first major trade deal since leaving the EUBritain has reached a free trade agreement with Japan, its first with a major economy since leaving the European Union earlier this year.
Read more »

EU tells UK to back down over Brexit bill, or elseEU tells UK to back down over Brexit bill, or elseUPDATED. EU vice president Maros Sefcovic tells senior British minister Michael Gove that unless the measures are withdrawn 'by the end of the month,' Brussels will consider taking legal action.
Read more »

WHO-led Solidarity trials for COVID-19 vaccines to start by end-October - DOH - Manila BulletinWHO-led Solidarity trials for COVID-19 vaccines to start by end-October - DOH - Manila BulletinThe World Health Organization (WHO)-led clinical trials for candidate vaccines against the coronavirus disease (COVID-19) in the country could start by the end of October, the Department of Health (DOH) said.
Read more »



Render Time: 2025-02-15 17:03:22